nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—NR3C1—epilepsy syndrome	0.244	0.674	CbGaD
Methylprednisolone—ABCB1—epilepsy syndrome	0.118	0.325	CbGaD
Methylprednisolone—ABCB1—Levetiracetam—epilepsy syndrome	0.0372	0.0906	CbGbCtD
Methylprednisolone—ABCB1—Clobazam—epilepsy syndrome	0.0258	0.0628	CbGbCtD
Methylprednisolone—ABCB1—Lamotrigine—epilepsy syndrome	0.0248	0.0605	CbGbCtD
Methylprednisolone—ABCB1—Carbamazepine—epilepsy syndrome	0.0213	0.0521	CbGbCtD
Methylprednisolone—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0204	0.0497	CbGbCtD
Methylprednisolone—ABCB1—Phenytoin—epilepsy syndrome	0.0191	0.0467	CbGbCtD
Methylprednisolone—CYP3A4—Felbamate—epilepsy syndrome	0.0189	0.0462	CbGbCtD
Methylprednisolone—CYP3A4—Trimethadione—epilepsy syndrome	0.0189	0.0462	CbGbCtD
Methylprednisolone—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0178	0.0434	CbGbCtD
Methylprednisolone—ABCB1—Phenobarbital—epilepsy syndrome	0.0171	0.0416	CbGbCtD
Methylprednisolone—ABCB1—Midazolam—epilepsy syndrome	0.0168	0.041	CbGbCtD
Methylprednisolone—ABCB1—Diazepam—epilepsy syndrome	0.0162	0.0395	CbGbCtD
Methylprednisolone—CYP3A4—Clonazepam—epilepsy syndrome	0.0161	0.0393	CbGbCtD
Methylprednisolone—CYP3A4—Clobazam—epilepsy syndrome	0.0154	0.0376	CbGbCtD
Methylprednisolone—CYP3A4—Rufinamide—epilepsy syndrome	0.0131	0.032	CbGbCtD
Methylprednisolone—CYP3A4—Carbamazepine—epilepsy syndrome	0.0128	0.0312	CbGbCtD
Methylprednisolone—CYP3A4—Primidone—epilepsy syndrome	0.0119	0.0291	CbGbCtD
Methylprednisolone—CYP3A4—Phenytoin—epilepsy syndrome	0.0115	0.028	CbGbCtD
Methylprednisolone—CYP3A4—Propofol—epilepsy syndrome	0.0107	0.0261	CbGbCtD
Methylprednisolone—CYP3A4—Acetazolamide—epilepsy syndrome	0.0102	0.0249	CbGbCtD
Methylprednisolone—CYP3A4—Phenobarbital—epilepsy syndrome	0.0102	0.0249	CbGbCtD
Methylprednisolone—CYP3A4—Midazolam—epilepsy syndrome	0.0101	0.0246	CbGbCtD
Methylprednisolone—CYP3A4—Diazepam—epilepsy syndrome	0.00969	0.0236	CbGbCtD
Methylprednisolone—CYP3A4—Zonisamide—epilepsy syndrome	0.00946	0.0231	CbGbCtD
Methylprednisolone—CYP3A4—Valproic Acid—epilepsy syndrome	0.00764	0.0186	CbGbCtD
Methylprednisolone—CYP3A4—Topiramate—epilepsy syndrome	0.00689	0.0168	CbGbCtD
Methylprednisolone—Prednisone—SLCO1A2—epilepsy syndrome	0.000173	0.038	CrCbGaD
Methylprednisolone—Prednisolone—SLCO1A2—epilepsy syndrome	0.000159	0.035	CrCbGaD
Methylprednisolone—Difluprednate—NR3C1—epilepsy syndrome	0.00015	0.0329	CrCbGaD
Methylprednisolone—Prednicarbate—NR3C1—epilepsy syndrome	0.000145	0.0319	CrCbGaD
Methylprednisolone—Clocortolone—NR3C1—epilepsy syndrome	0.000145	0.0319	CrCbGaD
Methylprednisolone—Diflorasone—NR3C1—epilepsy syndrome	0.000137	0.0302	CrCbGaD
Methylprednisolone—Desonide—NR3C1—epilepsy syndrome	0.000137	0.0302	CrCbGaD
Methylprednisolone—Desoximetasone—NR3C1—epilepsy syndrome	0.000134	0.0294	CrCbGaD
Methylprednisolone—Loteprednol—NR3C1—epilepsy syndrome	0.000132	0.0291	CrCbGaD
Methylprednisolone—Hydrocortisone—SLCO1A2—epilepsy syndrome	0.000122	0.0268	CrCbGaD
Methylprednisolone—Medrysone—NR3C1—epilepsy syndrome	0.000122	0.0267	CrCbGaD
Methylprednisolone—Flurandrenolide—NR3C1—epilepsy syndrome	0.000117	0.0258	CrCbGaD
Methylprednisolone—Flumethasone Pivalate—NR3C1—epilepsy syndrome	0.000115	0.0253	CrCbGaD
Methylprednisolone—Hydrocortamate—NR3C1—epilepsy syndrome	0.000113	0.0249	CrCbGaD
Methylprednisolone—Halobetasol Propionate—NR3C1—epilepsy syndrome	0.000113	0.0249	CrCbGaD
Methylprednisolone—Cortisone acetate—NR3C1—epilepsy syndrome	0.000112	0.0245	CrCbGaD
Methylprednisolone—Budesonide—NR3C1—epilepsy syndrome	0.000105	0.0232	CrCbGaD
Methylprednisolone—Mometasone—NR3C1—epilepsy syndrome	0.0001	0.022	CrCbGaD
Methylprednisolone—Rimexolone—NR3C1—epilepsy syndrome	9.91e-05	0.0218	CrCbGaD
Methylprednisolone—Fluocinonide—NR3C1—epilepsy syndrome	9.35e-05	0.0205	CrCbGaD
Methylprednisolone—Fluocinolone Acetonide—NR3C1—epilepsy syndrome	9.08e-05	0.02	CrCbGaD
Methylprednisolone—Alclometasone—NR3C1—epilepsy syndrome	9.08e-05	0.02	CrCbGaD
Methylprednisolone—Dexamethasone—SLCO1A2—epilepsy syndrome	9.08e-05	0.02	CrCbGaD
Methylprednisolone—Flunisolide—NR3C1—epilepsy syndrome	8.84e-05	0.0194	CrCbGaD
Methylprednisolone—Fludrocortisone—NR3C1—epilepsy syndrome	8.84e-05	0.0194	CrCbGaD
Methylprednisolone—Clobetasol propionate—NR3C1—epilepsy syndrome	8.84e-05	0.0194	CrCbGaD
Methylprednisolone—Paramethasone—NR3C1—epilepsy syndrome	8.73e-05	0.0192	CrCbGaD
Methylprednisolone—Ciclesonide—NR3C1—epilepsy syndrome	8.59e-05	0.0189	CrCbGaD
Methylprednisolone—Triamcinolone—BCHE—epilepsy syndrome	8.56e-05	0.0188	CrCbGaD
Methylprednisolone—Fluorometholone—NR3C1—epilepsy syndrome	8.52e-05	0.0187	CrCbGaD
Methylprednisolone—Dexamethasone—CYP11A1—epilepsy syndrome	7.9e-05	0.0174	CrCbGaD
Methylprednisolone—Triamcinolone—NR3C1—epilepsy syndrome	6.95e-05	0.0153	CrCbGaD
Methylprednisolone—Dexamethasone—NOS2—epilepsy syndrome	6.55e-05	0.0144	CrCbGaD
Methylprednisolone—Prednisone—NR3C1—epilepsy syndrome	6.3e-05	0.0139	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—NR3C1—epilepsy syndrome	6.27e-05	0.0138	CrCbGaD
Methylprednisolone—Fluticasone Propionate—NR3C1—epilepsy syndrome	6.21e-05	0.0137	CrCbGaD
Methylprednisolone—Prednisolone—NR3C1—epilepsy syndrome	5.81e-05	0.0128	CrCbGaD
Methylprednisolone—Ciclesonide—CYP2D6—epilepsy syndrome	5.81e-05	0.0128	CrCbGaD
Methylprednisolone—Prednisone—CYP2C19—epilepsy syndrome	5.74e-05	0.0126	CrCbGaD
Methylprednisolone—Betamethasone—NR3C1—epilepsy syndrome	5.69e-05	0.0125	CrCbGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—FOS—epilepsy syndrome	5.39e-05	0.00333	CbGpPWpGaD
Methylprednisolone—Malnutrition—Gabapentin—epilepsy syndrome	5.29e-05	0.000255	CcSEcCtD
Methylprednisolone—Erythema—Gabapentin—epilepsy syndrome	5.29e-05	0.000255	CcSEcCtD
Methylprednisolone—Angioedema—Pregabalin—epilepsy syndrome	5.27e-05	0.000254	CcSEcCtD
Methylprednisolone—Hypersensitivity—Clonazepam—epilepsy syndrome	5.27e-05	0.000254	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CCL2—epilepsy syndrome	5.26e-05	0.00326	CbGpPWpGaD
Methylprednisolone—Dizziness—Vigabatrin—epilepsy syndrome	5.26e-05	0.000254	CcSEcCtD
Methylprednisolone—Confusional state—Valproic Acid—epilepsy syndrome	5.25e-05	0.000254	CcSEcCtD
Methylprednisolone—Pruritus—Zonisamide—epilepsy syndrome	5.25e-05	0.000253	CcSEcCtD
Methylprednisolone—Hypersensitivity—Phenytoin—epilepsy syndrome	5.23e-05	0.000253	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Valproic Acid—epilepsy syndrome	5.21e-05	0.000251	CcSEcCtD
Methylprednisolone—Urticaria—Lamotrigine—epilepsy syndrome	5.21e-05	0.000251	CcSEcCtD
Methylprednisolone—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	5.21e-05	0.000251	CcSEcCtD
Methylprednisolone—Bradycardia—Topiramate—epilepsy syndrome	5.2e-05	0.000251	CcSEcCtD
Methylprednisolone—Malaise—Pregabalin—epilepsy syndrome	5.2e-05	0.000251	CcSEcCtD
Methylprednisolone—Nausea—Propofol—epilepsy syndrome	5.2e-05	0.000251	CcSEcCtD
Methylprednisolone—Vomiting—Fosphenytoin—epilepsy syndrome	5.19e-05	0.000251	CcSEcCtD
Methylprednisolone—Diarrhoea—Felbamate—epilepsy syndrome	5.19e-05	0.00025	CcSEcCtD
Methylprednisolone—Vertigo—Pregabalin—epilepsy syndrome	5.18e-05	0.00025	CcSEcCtD
Methylprednisolone—Abdominal pain—Lamotrigine—epilepsy syndrome	5.18e-05	0.00025	CcSEcCtD
Methylprednisolone—Dizziness—Diazepam—epilepsy syndrome	5.18e-05	0.00025	CcSEcCtD
Methylprednisolone—Infection—Valproic Acid—epilepsy syndrome	5.17e-05	0.00025	CcSEcCtD
Methylprednisolone—Syncope—Pregabalin—epilepsy syndrome	5.17e-05	0.00025	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—TH—epilepsy syndrome	5.15e-05	0.00319	CbGpPWpGaD
Methylprednisolone—Hydrocortisone—ABCG2—epilepsy syndrome	5.15e-05	0.0113	CrCbGaD
Methylprednisolone—Rash—Fosphenytoin—epilepsy syndrome	5.15e-05	0.000248	CcSEcCtD
Methylprednisolone—Dermatitis—Fosphenytoin—epilepsy syndrome	5.14e-05	0.000248	CcSEcCtD
Methylprednisolone—Haemoglobin—Topiramate—epilepsy syndrome	5.14e-05	0.000248	CcSEcCtD
Methylprednisolone—Asthenia—Clonazepam—epilepsy syndrome	5.13e-05	0.000248	CcSEcCtD
Methylprednisolone—Rhinitis—Topiramate—epilepsy syndrome	5.12e-05	0.000247	CcSEcCtD
Methylprednisolone—Headache—Fosphenytoin—epilepsy syndrome	5.11e-05	0.000247	CcSEcCtD
Methylprednisolone—Haemorrhage—Topiramate—epilepsy syndrome	5.11e-05	0.000247	CcSEcCtD
Methylprednisolone—Nervous system disorder—Valproic Acid—epilepsy syndrome	5.11e-05	0.000247	CcSEcCtD
Methylprednisolone—NR3C1—Adipogenesis—SOCS3—epilepsy syndrome	5.11e-05	0.00316	CbGpPWpGaD
Methylprednisolone—Asthenia—Phenytoin—epilepsy syndrome	5.1e-05	0.000246	CcSEcCtD
Methylprednisolone—Nausea—Midazolam—epilepsy syndrome	5.09e-05	0.000246	CcSEcCtD
Methylprednisolone—Hallucination—Topiramate—epilepsy syndrome	5.09e-05	0.000246	CcSEcCtD
Methylprednisolone—Tachycardia—Valproic Acid—epilepsy syndrome	5.08e-05	0.000245	CcSEcCtD
Methylprednisolone—Diarrhoea—Zonisamide—epilepsy syndrome	5.08e-05	0.000245	CcSEcCtD
Methylprednisolone—Loss of consciousness—Pregabalin—epilepsy syndrome	5.07e-05	0.000245	CcSEcCtD
Methylprednisolone—Asthenia—Oxcarbazepine—epilepsy syndrome	5.07e-05	0.000245	CcSEcCtD
Methylprednisolone—Pruritus—Clonazepam—epilepsy syndrome	5.06e-05	0.000244	CcSEcCtD
Methylprednisolone—Vomiting—Vigabatrin—epilepsy syndrome	5.06e-05	0.000244	CcSEcCtD
Methylprednisolone—Skin disorder—Valproic Acid—epilepsy syndrome	5.06e-05	0.000244	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Valproic Acid—epilepsy syndrome	5.03e-05	0.000243	CcSEcCtD
Methylprednisolone—Pruritus—Phenytoin—epilepsy syndrome	5.03e-05	0.000243	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Topiramate—epilepsy syndrome	5.02e-05	0.000243	CcSEcCtD
Methylprednisolone—Nausea—Levetiracetam—epilepsy syndrome	5.02e-05	0.000243	CcSEcCtD
Methylprednisolone—Rash—Vigabatrin—epilepsy syndrome	5.02e-05	0.000242	CcSEcCtD
Methylprednisolone—Dizziness—Felbamate—epilepsy syndrome	5.01e-05	0.000242	CcSEcCtD
Methylprednisolone—Dermatitis—Vigabatrin—epilepsy syndrome	5.01e-05	0.000242	CcSEcCtD
Methylprednisolone—Pruritus—Oxcarbazepine—epilepsy syndrome	5e-05	0.000241	CcSEcCtD
Methylprednisolone—Convulsion—Pregabalin—epilepsy syndrome	5e-05	0.000241	CcSEcCtD
Methylprednisolone—Hypersensitivity—Carbamazepine—epilepsy syndrome	5e-05	0.000241	CcSEcCtD
Methylprednisolone—Headache—Vigabatrin—epilepsy syndrome	4.98e-05	0.000241	CcSEcCtD
Methylprednisolone—Hypertension—Pregabalin—epilepsy syndrome	4.98e-05	0.00024	CcSEcCtD
Methylprednisolone—Vomiting—Diazepam—epilepsy syndrome	4.98e-05	0.00024	CcSEcCtD
Methylprednisolone—Rash—Diazepam—epilepsy syndrome	4.94e-05	0.000238	CcSEcCtD
Methylprednisolone—Dermatitis—Diazepam—epilepsy syndrome	4.93e-05	0.000238	CcSEcCtD
Methylprednisolone—Visual impairment—Topiramate—epilepsy syndrome	4.93e-05	0.000238	CcSEcCtD
Methylprednisolone—Myalgia—Pregabalin—epilepsy syndrome	4.91e-05	0.000237	CcSEcCtD
Methylprednisolone—Arthralgia—Pregabalin—epilepsy syndrome	4.91e-05	0.000237	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.91e-05	0.000237	CcSEcCtD
Methylprednisolone—Dizziness—Zonisamide—epilepsy syndrome	4.91e-05	0.000237	CcSEcCtD
Methylprednisolone—Headache—Diazepam—epilepsy syndrome	4.91e-05	0.000237	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—CXCL12—epilepsy syndrome	4.9e-05	0.00303	CbGpPWpGaD
Methylprednisolone—Anxiety—Pregabalin—epilepsy syndrome	4.89e-05	0.000236	CcSEcCtD
Methylprednisolone—Diarrhoea—Clonazepam—epilepsy syndrome	4.89e-05	0.000236	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.88e-05	0.000235	CcSEcCtD
Methylprednisolone—Hypotension—Valproic Acid—epilepsy syndrome	4.87e-05	0.000235	CcSEcCtD
Methylprednisolone—Asthenia—Carbamazepine—epilepsy syndrome	4.86e-05	0.000235	CcSEcCtD
Methylprednisolone—Diarrhoea—Phenytoin—epilepsy syndrome	4.86e-05	0.000235	CcSEcCtD
Methylprednisolone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	4.85e-05	0.003	CbGpPWpGaD
Methylprednisolone—Discomfort—Pregabalin—epilepsy syndrome	4.85e-05	0.000234	CcSEcCtD
Methylprednisolone—Nausea—Fosphenytoin—epilepsy syndrome	4.85e-05	0.000234	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—CD40—epilepsy syndrome	4.84e-05	0.003	CbGpPWpGaD
Methylprednisolone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.83e-05	0.000233	CcSEcCtD
Methylprednisolone—Angioedema—Gabapentin—epilepsy syndrome	4.83e-05	0.000233	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of Androgen receptor activity—JUN—epilepsy syndrome	4.83e-05	0.00299	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.83e-05	0.000233	CcSEcCtD
Methylprednisolone—Vomiting—Felbamate—epilepsy syndrome	4.82e-05	0.000233	CcSEcCtD
Methylprednisolone—Pruritus—Carbamazepine—epilepsy syndrome	4.8e-05	0.000232	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—epilepsy syndrome	4.79e-05	0.00297	CbGpPWpGaD
Methylprednisolone—Rash—Felbamate—epilepsy syndrome	4.78e-05	0.000231	CcSEcCtD
Methylprednisolone—Eye disorder—Topiramate—epilepsy syndrome	4.78e-05	0.000231	CcSEcCtD
Methylprednisolone—Dermatitis—Felbamate—epilepsy syndrome	4.77e-05	0.000231	CcSEcCtD
Methylprednisolone—Malaise—Gabapentin—epilepsy syndrome	4.77e-05	0.00023	CcSEcCtD
Methylprednisolone—Vertigo—Gabapentin—epilepsy syndrome	4.75e-05	0.000229	CcSEcCtD
Methylprednisolone—Headache—Felbamate—epilepsy syndrome	4.75e-05	0.000229	CcSEcCtD
Methylprednisolone—Confusional state—Pregabalin—epilepsy syndrome	4.75e-05	0.000229	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—FOS—epilepsy syndrome	4.75e-05	0.00294	CbGpPWpGaD
Methylprednisolone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.74e-05	0.000229	CcSEcCtD
Methylprednisolone—Cardiac disorder—Topiramate—epilepsy syndrome	4.74e-05	0.000229	CcSEcCtD
Methylprednisolone—Syncope—Gabapentin—epilepsy syndrome	4.74e-05	0.000229	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—POMC—epilepsy syndrome	4.74e-05	0.00293	CbGpPWpGaD
Methylprednisolone—Dizziness—Clonazepam—epilepsy syndrome	4.73e-05	0.000228	CcSEcCtD
Methylprednisolone—Nausea—Vigabatrin—epilepsy syndrome	4.72e-05	0.000228	CcSEcCtD
Methylprednisolone—Vomiting—Zonisamide—epilepsy syndrome	4.72e-05	0.000228	CcSEcCtD
Methylprednisolone—Insomnia—Valproic Acid—epilepsy syndrome	4.71e-05	0.000227	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Pregabalin—epilepsy syndrome	4.71e-05	0.000227	CcSEcCtD
Methylprednisolone—Asthenia—Lamotrigine—epilepsy syndrome	4.7e-05	0.000227	CcSEcCtD
Methylprednisolone—Dizziness—Phenytoin—epilepsy syndrome	4.7e-05	0.000227	CcSEcCtD
Methylprednisolone—Rash—Zonisamide—epilepsy syndrome	4.68e-05	0.000226	CcSEcCtD
Methylprednisolone—Infection—Pregabalin—epilepsy syndrome	4.68e-05	0.000226	CcSEcCtD
Methylprednisolone—Paraesthesia—Valproic Acid—epilepsy syndrome	4.68e-05	0.000226	CcSEcCtD
Methylprednisolone—Dermatitis—Zonisamide—epilepsy syndrome	4.67e-05	0.000226	CcSEcCtD
Methylprednisolone—Dizziness—Oxcarbazepine—epilepsy syndrome	4.67e-05	0.000226	CcSEcCtD
Methylprednisolone—Nausea—Diazepam—epilepsy syndrome	4.65e-05	0.000225	CcSEcCtD
Methylprednisolone—Loss of consciousness—Gabapentin—epilepsy syndrome	4.65e-05	0.000224	CcSEcCtD
Methylprednisolone—Headache—Zonisamide—epilepsy syndrome	4.65e-05	0.000224	CcSEcCtD
Methylprednisolone—Diarrhoea—Carbamazepine—epilepsy syndrome	4.64e-05	0.000224	CcSEcCtD
Methylprednisolone—Angiopathy—Topiramate—epilepsy syndrome	4.64e-05	0.000224	CcSEcCtD
Methylprednisolone—Pruritus—Lamotrigine—epilepsy syndrome	4.64e-05	0.000224	CcSEcCtD
Methylprednisolone—Shock—Pregabalin—epilepsy syndrome	4.63e-05	0.000224	CcSEcCtD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	4.62e-05	0.00286	CbGpPWpGaD
Methylprednisolone—Immune system disorder—Topiramate—epilepsy syndrome	4.62e-05	0.000223	CcSEcCtD
Methylprednisolone—Nervous system disorder—Pregabalin—epilepsy syndrome	4.62e-05	0.000223	CcSEcCtD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	4.61e-05	0.00285	CbGpPWpGaD
Methylprednisolone—Mediastinal disorder—Topiramate—epilepsy syndrome	4.61e-05	0.000222	CcSEcCtD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—HMOX1—epilepsy syndrome	4.6e-05	0.00285	CbGpPWpGaD
Methylprednisolone—Tachycardia—Pregabalin—epilepsy syndrome	4.59e-05	0.000222	CcSEcCtD
Methylprednisolone—Dyspepsia—Valproic Acid—epilepsy syndrome	4.58e-05	0.000221	CcSEcCtD
Methylprednisolone—Convulsion—Gabapentin—epilepsy syndrome	4.58e-05	0.000221	CcSEcCtD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	4.58e-05	0.00284	CbGpPWpGaD
Methylprednisolone—Skin disorder—Pregabalin—epilepsy syndrome	4.57e-05	0.000221	CcSEcCtD
Methylprednisolone—Hypertension—Gabapentin—epilepsy syndrome	4.57e-05	0.00022	CcSEcCtD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	4.55e-05	0.00282	CbGpPWpGaD
Methylprednisolone—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.55e-05	0.00022	CcSEcCtD
Methylprednisolone—Vomiting—Clonazepam—epilepsy syndrome	4.55e-05	0.00022	CcSEcCtD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	4.52e-05	0.0028	CbGpPWpGaD
Methylprednisolone—Vomiting—Phenytoin—epilepsy syndrome	4.52e-05	0.000218	CcSEcCtD
Methylprednisolone—NR3C1—Adipogenesis—MEF2C—epilepsy syndrome	4.51e-05	0.00279	CbGpPWpGaD
Methylprednisolone—Rash—Clonazepam—epilepsy syndrome	4.51e-05	0.000218	CcSEcCtD
Methylprednisolone—Dermatitis—Clonazepam—epilepsy syndrome	4.5e-05	0.000218	CcSEcCtD
Methylprednisolone—Myalgia—Gabapentin—epilepsy syndrome	4.5e-05	0.000217	CcSEcCtD
Methylprednisolone—Arthralgia—Gabapentin—epilepsy syndrome	4.5e-05	0.000217	CcSEcCtD
Methylprednisolone—Nausea—Felbamate—epilepsy syndrome	4.5e-05	0.000217	CcSEcCtD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	4.49e-05	0.00278	CbGpPWpGaD
Methylprednisolone—Vomiting—Oxcarbazepine—epilepsy syndrome	4.49e-05	0.000217	CcSEcCtD
Methylprednisolone—Fatigue—Valproic Acid—epilepsy syndrome	4.49e-05	0.000217	CcSEcCtD
Methylprednisolone—Anxiety—Gabapentin—epilepsy syndrome	4.49e-05	0.000217	CcSEcCtD
Methylprednisolone—Dizziness—Carbamazepine—epilepsy syndrome	4.48e-05	0.000216	CcSEcCtD
Methylprednisolone—Diarrhoea—Lamotrigine—epilepsy syndrome	4.48e-05	0.000216	CcSEcCtD
Methylprednisolone—Headache—Clonazepam—epilepsy syndrome	4.48e-05	0.000216	CcSEcCtD
Methylprednisolone—Rash—Phenytoin—epilepsy syndrome	4.48e-05	0.000216	CcSEcCtD
Methylprednisolone—Mental disorder—Topiramate—epilepsy syndrome	4.48e-05	0.000216	CcSEcCtD
Methylprednisolone—Dermatitis—Phenytoin—epilepsy syndrome	4.47e-05	0.000216	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.47e-05	0.000216	CcSEcCtD
Methylprednisolone—Rash—Oxcarbazepine—epilepsy syndrome	4.45e-05	0.000215	CcSEcCtD
Methylprednisolone—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.45e-05	0.000215	CcSEcCtD
Methylprednisolone—Headache—Phenytoin—epilepsy syndrome	4.45e-05	0.000215	CcSEcCtD
Methylprednisolone—Erythema—Topiramate—epilepsy syndrome	4.45e-05	0.000215	CcSEcCtD
Methylprednisolone—Malnutrition—Topiramate—epilepsy syndrome	4.45e-05	0.000215	CcSEcCtD
Methylprednisolone—Discomfort—Gabapentin—epilepsy syndrome	4.45e-05	0.000215	CcSEcCtD
Methylprednisolone—Hydrocortisone—NR3C1—epilepsy syndrome	4.44e-05	0.00977	CrCbGaD
Methylprednisolone—Headache—Oxcarbazepine—epilepsy syndrome	4.43e-05	0.000214	CcSEcCtD
Methylprednisolone—Nausea—Zonisamide—epilepsy syndrome	4.41e-05	0.000213	CcSEcCtD
Methylprednisolone—Hypotension—Pregabalin—epilepsy syndrome	4.4e-05	0.000212	CcSEcCtD
Methylprednisolone—Confusional state—Gabapentin—epilepsy syndrome	4.35e-05	0.00021	CcSEcCtD
Methylprednisolone—Dexamethasone—ABCC2—epilepsy syndrome	4.34e-05	0.00954	CrCbGaD
Methylprednisolone—NR3C1—Regulation of Androgen receptor activity—SRC—epilepsy syndrome	4.33e-05	0.00268	CbGpPWpGaD
Methylprednisolone—Dizziness—Lamotrigine—epilepsy syndrome	4.33e-05	0.000209	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.32e-05	0.000208	CcSEcCtD
Methylprednisolone—Vomiting—Carbamazepine—epilepsy syndrome	4.31e-05	0.000208	CcSEcCtD
Methylprednisolone—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.29e-05	0.000207	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.29e-05	0.000207	CcSEcCtD
Methylprednisolone—Infection—Gabapentin—epilepsy syndrome	4.29e-05	0.000207	CcSEcCtD
Methylprednisolone—Rash—Carbamazepine—epilepsy syndrome	4.27e-05	0.000206	CcSEcCtD
Methylprednisolone—Dermatitis—Carbamazepine—epilepsy syndrome	4.27e-05	0.000206	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	4.26e-05	0.00264	CbGpPWpGaD
Methylprednisolone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.26e-05	0.000206	CcSEcCtD
Methylprednisolone—Insomnia—Pregabalin—epilepsy syndrome	4.26e-05	0.000206	CcSEcCtD
Methylprednisolone—Nausea—Clonazepam—epilepsy syndrome	4.25e-05	0.000205	CcSEcCtD
Methylprednisolone—Headache—Carbamazepine—epilepsy syndrome	4.25e-05	0.000205	CcSEcCtD
Methylprednisolone—Shock—Gabapentin—epilepsy syndrome	4.25e-05	0.000205	CcSEcCtD
Methylprednisolone—Nervous system disorder—Gabapentin—epilepsy syndrome	4.23e-05	0.000204	CcSEcCtD
Methylprednisolone—Paraesthesia—Pregabalin—epilepsy syndrome	4.23e-05	0.000204	CcSEcCtD
Methylprednisolone—Nausea—Phenytoin—epilepsy syndrome	4.22e-05	0.000204	CcSEcCtD
Methylprednisolone—Tachycardia—Gabapentin—epilepsy syndrome	4.21e-05	0.000203	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	4.2e-05	0.0026	CbGpPWpGaD
Methylprednisolone—Nausea—Oxcarbazepine—epilepsy syndrome	4.2e-05	0.000203	CcSEcCtD
Methylprednisolone—Skin disorder—Gabapentin—epilepsy syndrome	4.19e-05	0.000202	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.17e-05	0.000202	CcSEcCtD
Methylprednisolone—Vomiting—Lamotrigine—epilepsy syndrome	4.17e-05	0.000201	CcSEcCtD
Methylprednisolone—Urticaria—Valproic Acid—epilepsy syndrome	4.14e-05	0.0002	CcSEcCtD
Methylprednisolone—Rash—Lamotrigine—epilepsy syndrome	4.13e-05	0.0002	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Topiramate—epilepsy syndrome	4.13e-05	0.000199	CcSEcCtD
Methylprednisolone—Dermatitis—Lamotrigine—epilepsy syndrome	4.13e-05	0.000199	CcSEcCtD
Methylprednisolone—Abdominal pain—Valproic Acid—epilepsy syndrome	4.12e-05	0.000199	CcSEcCtD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	4.11e-05	0.00254	CbGpPWpGaD
Methylprednisolone—Headache—Lamotrigine—epilepsy syndrome	4.1e-05	0.000198	CcSEcCtD
Methylprednisolone—Fatigue—Pregabalin—epilepsy syndrome	4.06e-05	0.000196	CcSEcCtD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	4.06e-05	0.00251	CbGpPWpGaD
Methylprednisolone—Hypotension—Gabapentin—epilepsy syndrome	4.03e-05	0.000195	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	4.03e-05	0.00249	CbGpPWpGaD
Methylprednisolone—Nausea—Carbamazepine—epilepsy syndrome	4.03e-05	0.000194	CcSEcCtD
Methylprednisolone—Malaise—Topiramate—epilepsy syndrome	4.01e-05	0.000194	CcSEcCtD
Methylprednisolone—Vertigo—Topiramate—epilepsy syndrome	4e-05	0.000193	CcSEcCtD
Methylprednisolone—Syncope—Topiramate—epilepsy syndrome	3.99e-05	0.000193	CcSEcCtD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	3.98e-05	0.00246	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	3.98e-05	0.00246	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—WARS—epilepsy syndrome	3.97e-05	0.00246	CbGpPWpGaD
Methylprednisolone—Triamcinolone—PTGS2—epilepsy syndrome	3.94e-05	0.00867	CrCbGaD
Methylprednisolone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.93e-05	0.00019	CcSEcCtD
Methylprednisolone—Loss of consciousness—Topiramate—epilepsy syndrome	3.91e-05	0.000189	CcSEcCtD
Methylprednisolone—Insomnia—Gabapentin—epilepsy syndrome	3.9e-05	0.000189	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	3.9e-05	0.00241	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—AGT—epilepsy syndrome	3.89e-05	0.00241	CbGpPWpGaD
Methylprednisolone—Nausea—Lamotrigine—epilepsy syndrome	3.89e-05	0.000188	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—RELA—epilepsy syndrome	3.89e-05	0.00241	CbGpPWpGaD
Methylprednisolone—Feeling abnormal—Pregabalin—epilepsy syndrome	3.88e-05	0.000187	CcSEcCtD
Methylprednisolone—Paraesthesia—Gabapentin—epilepsy syndrome	3.88e-05	0.000187	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—JUN—epilepsy syndrome	3.87e-05	0.00239	CbGpPWpGaD
Methylprednisolone—Convulsion—Topiramate—epilepsy syndrome	3.86e-05	0.000186	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.85e-05	0.000186	CcSEcCtD
Methylprednisolone—Hypertension—Topiramate—epilepsy syndrome	3.84e-05	0.000186	CcSEcCtD
Methylprednisolone—Dexamethasone—ABCG2—epilepsy syndrome	3.84e-05	0.00844	CrCbGaD
Methylprednisolone—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.84e-05	0.000185	CcSEcCtD
Methylprednisolone—Dyspepsia—Gabapentin—epilepsy syndrome	3.8e-05	0.000183	CcSEcCtD
Methylprednisolone—Myalgia—Topiramate—epilepsy syndrome	3.79e-05	0.000183	CcSEcCtD
Methylprednisolone—Arthralgia—Topiramate—epilepsy syndrome	3.79e-05	0.000183	CcSEcCtD
Methylprednisolone—Anxiety—Topiramate—epilepsy syndrome	3.78e-05	0.000182	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	3.77e-05	0.00233	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—MMP9—epilepsy syndrome	3.76e-05	0.00233	CbGpPWpGaD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.76e-05	0.000182	CcSEcCtD
Methylprednisolone—Discomfort—Topiramate—epilepsy syndrome	3.74e-05	0.000181	CcSEcCtD
Methylprednisolone—Urticaria—Pregabalin—epilepsy syndrome	3.74e-05	0.000181	CcSEcCtD
Methylprednisolone—Asthenia—Valproic Acid—epilepsy syndrome	3.74e-05	0.00018	CcSEcCtD
Methylprednisolone—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	3.73e-05	0.00231	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	3.73e-05	0.00231	CbGpPWpGaD
Methylprednisolone—Fatigue—Gabapentin—epilepsy syndrome	3.72e-05	0.00018	CcSEcCtD
Methylprednisolone—Abdominal pain—Pregabalin—epilepsy syndrome	3.72e-05	0.00018	CcSEcCtD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	3.71e-05	0.0023	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	3.69e-05	0.00228	CbGpPWpGaD
Methylprednisolone—Pruritus—Valproic Acid—epilepsy syndrome	3.68e-05	0.000178	CcSEcCtD
Methylprednisolone—Confusional state—Topiramate—epilepsy syndrome	3.66e-05	0.000177	CcSEcCtD
Methylprednisolone—Infection—Topiramate—epilepsy syndrome	3.61e-05	0.000174	CcSEcCtD
Methylprednisolone—NR3C1—Adipogenesis—IL6ST—epilepsy syndrome	3.58e-05	0.00222	CbGpPWpGaD
Methylprednisolone—Shock—Topiramate—epilepsy syndrome	3.57e-05	0.000173	CcSEcCtD
Methylprednisolone—Diarrhoea—Valproic Acid—epilepsy syndrome	3.56e-05	0.000172	CcSEcCtD
Methylprednisolone—Nervous system disorder—Topiramate—epilepsy syndrome	3.56e-05	0.000172	CcSEcCtD
Methylprednisolone—Feeling abnormal—Gabapentin—epilepsy syndrome	3.56e-05	0.000172	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	3.55e-05	0.00219	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	3.54e-05	0.00219	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	3.54e-05	0.00219	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	3.54e-05	0.00219	CbGpPWpGaD
Methylprednisolone—Tachycardia—Topiramate—epilepsy syndrome	3.54e-05	0.000171	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.53e-05	0.00017	CcSEcCtD
Methylprednisolone—Skin disorder—Topiramate—epilepsy syndrome	3.53e-05	0.00017	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Topiramate—epilepsy syndrome	3.51e-05	0.00017	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—epilepsy syndrome	3.49e-05	0.00216	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—epilepsy syndrome	3.49e-05	0.00216	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Pregabalin—epilepsy syndrome	3.47e-05	0.000167	CcSEcCtD
Methylprednisolone—Dizziness—Valproic Acid—epilepsy syndrome	3.44e-05	0.000166	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—epilepsy syndrome	3.44e-05	0.00213	CbGpPWpGaD
Methylprednisolone—Urticaria—Gabapentin—epilepsy syndrome	3.43e-05	0.000166	CcSEcCtD
Methylprednisolone—Abdominal pain—Gabapentin—epilepsy syndrome	3.41e-05	0.000165	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—JUN—epilepsy syndrome	3.41e-05	0.00211	CbGpPWpGaD
Methylprednisolone—Hypotension—Topiramate—epilepsy syndrome	3.39e-05	0.000164	CcSEcCtD
Methylprednisolone—Asthenia—Pregabalin—epilepsy syndrome	3.38e-05	0.000163	CcSEcCtD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	3.33e-05	0.00206	CbGpPWpGaD
Methylprednisolone—Pruritus—Pregabalin—epilepsy syndrome	3.33e-05	0.000161	CcSEcCtD
Methylprednisolone—Dexamethasone—NR3C1—epilepsy syndrome	3.31e-05	0.00728	CrCbGaD
Methylprednisolone—Vomiting—Valproic Acid—epilepsy syndrome	3.31e-05	0.00016	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.31e-05	0.00016	CcSEcCtD
Methylprednisolone—Insomnia—Topiramate—epilepsy syndrome	3.28e-05	0.000159	CcSEcCtD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—NOS2—epilepsy syndrome	3.28e-05	0.00203	CbGpPWpGaD
Methylprednisolone—Rash—Valproic Acid—epilepsy syndrome	3.28e-05	0.000159	CcSEcCtD
Methylprednisolone—Dermatitis—Valproic Acid—epilepsy syndrome	3.28e-05	0.000158	CcSEcCtD
Methylprednisolone—Headache—Valproic Acid—epilepsy syndrome	3.26e-05	0.000158	CcSEcCtD
Methylprednisolone—Paraesthesia—Topiramate—epilepsy syndrome	3.26e-05	0.000157	CcSEcCtD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	3.24e-05	0.00201	CbGpPWpGaD
Methylprednisolone—Betamethasone—PTGS2—epilepsy syndrome	3.23e-05	0.0071	CrCbGaD
Methylprednisolone—Diarrhoea—Pregabalin—epilepsy syndrome	3.22e-05	0.000156	CcSEcCtD
Methylprednisolone—Dyspepsia—Topiramate—epilepsy syndrome	3.2e-05	0.000154	CcSEcCtD
Methylprednisolone—Prednisone—ALB—epilepsy syndrome	3.19e-05	0.007	CrCbGaD
Methylprednisolone—Hypersensitivity—Gabapentin—epilepsy syndrome	3.18e-05	0.000154	CcSEcCtD
Methylprednisolone—Fatigue—Topiramate—epilepsy syndrome	3.13e-05	0.000151	CcSEcCtD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	3.13e-05	0.00193	CbGpPWpGaD
Methylprednisolone—Dizziness—Pregabalin—epilepsy syndrome	3.11e-05	0.00015	CcSEcCtD
Methylprednisolone—Asthenia—Gabapentin—epilepsy syndrome	3.1e-05	0.00015	CcSEcCtD
Methylprednisolone—Nausea—Valproic Acid—epilepsy syndrome	3.09e-05	0.000149	CcSEcCtD
Methylprednisolone—Pruritus—Gabapentin—epilepsy syndrome	3.05e-05	0.000147	CcSEcCtD
Methylprednisolone—Prednisone—ABCB1—epilepsy syndrome	3.04e-05	0.00668	CrCbGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—FOS—epilepsy syndrome	3.03e-05	0.00188	CbGpPWpGaD
Methylprednisolone—Dexamethasone—CYP2C19—epilepsy syndrome	3.02e-05	0.00663	CrCbGaD
Methylprednisolone—NR3C1—Gene Expression—QARS—epilepsy syndrome	3.01e-05	0.00186	CbGpPWpGaD
Methylprednisolone—Vomiting—Pregabalin—epilepsy syndrome	2.99e-05	0.000145	CcSEcCtD
Methylprednisolone—Feeling abnormal—Topiramate—epilepsy syndrome	2.99e-05	0.000145	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.97e-05	0.000143	CcSEcCtD
Methylprednisolone—Rash—Pregabalin—epilepsy syndrome	2.97e-05	0.000143	CcSEcCtD
Methylprednisolone—Dermatitis—Pregabalin—epilepsy syndrome	2.97e-05	0.000143	CcSEcCtD
Methylprednisolone—Diarrhoea—Gabapentin—epilepsy syndrome	2.95e-05	0.000143	CcSEcCtD
Methylprednisolone—Headache—Pregabalin—epilepsy syndrome	2.95e-05	0.000142	CcSEcCtD
Methylprednisolone—Urticaria—Topiramate—epilepsy syndrome	2.88e-05	0.000139	CcSEcCtD
Methylprednisolone—Abdominal pain—Topiramate—epilepsy syndrome	2.87e-05	0.000139	CcSEcCtD
Methylprednisolone—Dizziness—Gabapentin—epilepsy syndrome	2.85e-05	0.000138	CcSEcCtD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	2.83e-05	0.00175	CbGpPWpGaD
Methylprednisolone—Prednisolone—ABCB1—epilepsy syndrome	2.8e-05	0.00616	CrCbGaD
Methylprednisolone—Nausea—Pregabalin—epilepsy syndrome	2.8e-05	0.000135	CcSEcCtD
Methylprednisolone—Betamethasone—ABCB1—epilepsy syndrome	2.75e-05	0.00604	CrCbGaD
Methylprednisolone—Vomiting—Gabapentin—epilepsy syndrome	2.74e-05	0.000133	CcSEcCtD
Methylprednisolone—Rash—Gabapentin—epilepsy syndrome	2.72e-05	0.000131	CcSEcCtD
Methylprednisolone—Dermatitis—Gabapentin—epilepsy syndrome	2.72e-05	0.000131	CcSEcCtD
Methylprednisolone—Headache—Gabapentin—epilepsy syndrome	2.7e-05	0.000131	CcSEcCtD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	2.69e-05	0.00166	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	2.69e-05	0.00166	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	2.69e-05	0.00166	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Topiramate—epilepsy syndrome	2.68e-05	0.000129	CcSEcCtD
Methylprednisolone—Asthenia—Topiramate—epilepsy syndrome	2.61e-05	0.000126	CcSEcCtD
Methylprednisolone—Pruritus—Topiramate—epilepsy syndrome	2.57e-05	0.000124	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—CASP8—epilepsy syndrome	2.57e-05	0.00159	CbGpPWpGaD
Methylprednisolone—Nausea—Gabapentin—epilepsy syndrome	2.56e-05	0.000124	CcSEcCtD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	2.56e-05	0.00159	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	2.56e-05	0.00159	CbGpPWpGaD
Methylprednisolone—Diarrhoea—Topiramate—epilepsy syndrome	2.48e-05	0.00012	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—EIF2B5—epilepsy syndrome	2.41e-05	0.00149	CbGpPWpGaD
Methylprednisolone—Dizziness—Topiramate—epilepsy syndrome	2.4e-05	0.000116	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	2.37e-05	0.00147	CbGpPWpGaD
Methylprednisolone—Vomiting—Topiramate—epilepsy syndrome	2.31e-05	0.000111	CcSEcCtD
Methylprednisolone—Rash—Topiramate—epilepsy syndrome	2.29e-05	0.000111	CcSEcCtD
Methylprednisolone—Dermatitis—Topiramate—epilepsy syndrome	2.29e-05	0.00011	CcSEcCtD
Methylprednisolone—Headache—Topiramate—epilepsy syndrome	2.27e-05	0.00011	CcSEcCtD
Methylprednisolone—Dexamethasone—CYP2D6—epilepsy syndrome	2.24e-05	0.00492	CrCbGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—JUNB—epilepsy syndrome	2.19e-05	0.00136	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CA13—epilepsy syndrome	2.19e-05	0.00136	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—JUN—epilepsy syndrome	2.18e-05	0.00135	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—TFAM—epilepsy syndrome	2.18e-05	0.00135	CbGpPWpGaD
Methylprednisolone—Nausea—Topiramate—epilepsy syndrome	2.16e-05	0.000104	CcSEcCtD
Methylprednisolone—Hydrocortisone—ABCB1—epilepsy syndrome	2.14e-05	0.00471	CrCbGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	2.1e-05	0.0013	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	2.1e-05	0.0013	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	2.09e-05	0.00129	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	2.04e-05	0.00126	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	2.04e-05	0.00126	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	2.04e-05	0.00126	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.01e-05	0.00125	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	1.97e-05	0.00122	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	1.96e-05	0.00121	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL1B—epilepsy syndrome	1.95e-05	0.0012	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	1.95e-05	0.0012	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	1.94e-05	0.0012	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CASP3—epilepsy syndrome	1.94e-05	0.0012	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.93e-05	0.0012	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	1.92e-05	0.00119	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	1.92e-05	0.00119	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	1.91e-05	0.00118	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—epilepsy syndrome	1.9e-05	0.00118	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—epilepsy syndrome	1.9e-05	0.00118	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SNRPE—epilepsy syndrome	1.88e-05	0.00116	CbGpPWpGaD
Methylprednisolone—Dexamethasone—PTGS2—epilepsy syndrome	1.88e-05	0.00413	CrCbGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	1.86e-05	0.00115	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	1.86e-05	0.00115	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	1.86e-05	0.00115	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	1.86e-05	0.00115	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	1.78e-05	0.0011	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	1.77e-05	0.0011	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—TNF—epilepsy syndrome	1.76e-05	0.00109	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.75e-05	0.00108	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—VDR—epilepsy syndrome	1.74e-05	0.00108	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	1.73e-05	0.00107	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ADK—epilepsy syndrome	1.66e-05	0.00103	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CERS1—epilepsy syndrome	1.66e-05	0.00103	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—L2HGDH—epilepsy syndrome	1.66e-05	0.00103	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GLUD1—epilepsy syndrome	1.66e-05	0.00103	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—FAR1—epilepsy syndrome	1.66e-05	0.00103	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PDXK—epilepsy syndrome	1.66e-05	0.00103	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	1.65e-05	0.00102	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—VEGFA—epilepsy syndrome	1.65e-05	0.00102	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.63e-05	0.00101	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	1.63e-05	0.00101	CbGpPWpGaD
Methylprednisolone—Dexamethasone—ABCB1—epilepsy syndrome	1.6e-05	0.00351	CrCbGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	1.58e-05	0.00098	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	1.53e-05	0.000944	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	1.52e-05	0.000943	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NHLRC1—epilepsy syndrome	1.52e-05	0.00094	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—EPM2A—epilepsy syndrome	1.52e-05	0.00094	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GAMT—epilepsy syndrome	1.52e-05	0.00094	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PNPO—epilepsy syndrome	1.52e-05	0.00094	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	1.47e-05	0.000911	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	1.47e-05	0.000911	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	1.45e-05	0.000898	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	1.41e-05	0.000874	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—QDPR—epilepsy syndrome	1.41e-05	0.000874	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CA4—epilepsy syndrome	1.41e-05	0.000874	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	1.41e-05	0.000873	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.35e-05	0.000835	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—COX3—epilepsy syndrome	1.33e-05	0.000821	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.31e-05	0.000812	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—EIF2S1—epilepsy syndrome	1.31e-05	0.000811	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.27e-05	0.000784	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—HSPB1—epilepsy syndrome	1.26e-05	0.000783	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.26e-05	0.000779	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.26e-05	0.000779	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.26e-05	0.000779	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.26e-05	0.000779	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.26e-05	0.000779	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.21e-05	0.000751	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.2e-05	0.000743	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.17e-05	0.000724	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.15e-05	0.000712	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.15e-05	0.000712	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.15e-05	0.000712	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.14e-05	0.000708	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.11e-05	0.000686	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.09e-05	0.000673	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	1.07e-05	0.000662	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GBE1—epilepsy syndrome	1.07e-05	0.000662	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—JUNB—epilepsy syndrome	1.06e-05	0.000653	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.03e-05	0.000639	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.02e-05	0.000633	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.02e-05	0.000633	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.02e-05	0.000633	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.02e-05	0.000633	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.02e-05	0.000633	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.02e-05	0.000633	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.01e-05	0.000623	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	9.94e-06	0.000615	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—STXBP1—epilepsy syndrome	9.78e-06	0.000606	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	9.58e-06	0.000593	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NT5E—epilepsy syndrome	9.54e-06	0.00059	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALAD—epilepsy syndrome	9.54e-06	0.00059	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	9.48e-06	0.000587	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PNPO—epilepsy syndrome	9.35e-06	0.000579	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GAMT—epilepsy syndrome	9.35e-06	0.000579	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	9.35e-06	0.000579	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	9.35e-06	0.000579	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	9.31e-06	0.000576	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	9.1e-06	0.000563	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	9.1e-06	0.000563	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	8.9e-06	0.000551	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ADSL—epilepsy syndrome	8.72e-06	0.00054	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—QDPR—epilepsy syndrome	8.7e-06	0.000538	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CA4—epilepsy syndrome	8.7e-06	0.000538	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	8.67e-06	0.000537	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GLUL—epilepsy syndrome	8.55e-06	0.000529	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SIRT1—epilepsy syndrome	8.5e-06	0.000526	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	8.39e-06	0.00052	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—VDR—epilepsy syndrome	8.38e-06	0.000519	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	8.35e-06	0.000517	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—COX3—epilepsy syndrome	8.18e-06	0.000506	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	8.13e-06	0.000503	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—H2AFX—epilepsy syndrome	7.94e-06	0.000492	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	7.85e-06	0.000486	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	7.8e-06	0.000483	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	7.75e-06	0.00048	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PFKL—epilepsy syndrome	7.75e-06	0.00048	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	7.75e-06	0.00048	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	7.75e-06	0.00048	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	7.75e-06	0.00048	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	7.73e-06	0.000479	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—YWHAZ—epilepsy syndrome	7.66e-06	0.000474	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AQP1—epilepsy syndrome	7.62e-06	0.000472	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ATIC—epilepsy syndrome	7.09e-06	0.000439	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—UPB1—epilepsy syndrome	7.09e-06	0.000439	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NEU1—epilepsy syndrome	7.09e-06	0.000439	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	6.97e-06	0.000431	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	6.89e-06	0.000427	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CHRM3—epilepsy syndrome	6.89e-06	0.000427	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	6.82e-06	0.000422	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	6.59e-06	0.000408	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GBE1—epilepsy syndrome	6.59e-06	0.000408	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	6.2e-06	0.000384	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	6.03e-06	0.000373	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NT5E—epilepsy syndrome	5.87e-06	0.000364	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALAD—epilepsy syndrome	5.87e-06	0.000364	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ABCG2—epilepsy syndrome	5.62e-06	0.000348	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	5.6e-06	0.000347	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	5.6e-06	0.000347	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	5.48e-06	0.000339	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	5.48e-06	0.000339	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	5.44e-06	0.000337	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ADSL—epilepsy syndrome	5.37e-06	0.000333	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GLUL—epilepsy syndrome	5.27e-06	0.000326	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	5.19e-06	0.000321	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	5.17e-06	0.00032	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	4.91e-06	0.000304	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.84e-06	0.000299	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.7e-06	0.000291	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.68e-06	0.00029	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	4.68e-06	0.000289	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—BCHE—epilepsy syndrome	4.66e-06	0.000288	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	4.44e-06	0.000275	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PLCB1—epilepsy syndrome	4.39e-06	0.000272	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—TH—epilepsy syndrome	4.38e-06	0.000271	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	4.25e-06	0.000263	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	4.25e-06	0.000263	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HMOX1—epilepsy syndrome	3.65e-06	0.000226	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CAT—epilepsy syndrome	3.61e-06	0.000223	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.46e-06	0.000214	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.37e-06	0.000209	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.35e-06	0.000208	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GPX1—epilepsy syndrome	3.26e-06	0.000202	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.03e-06	0.000187	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.88e-06	0.000178	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.87e-06	0.000178	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AGT—epilepsy syndrome	2.86e-06	0.000177	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—APOE—epilepsy syndrome	2.8e-06	0.000173	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.74e-06	0.000169	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.71e-06	0.000168	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—TH—epilepsy syndrome	2.7e-06	0.000167	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—POMC—epilepsy syndrome	2.41e-06	0.000149	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—AKT1—epilepsy syndrome	2.31e-06	0.000143	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.25e-06	0.000139	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.22e-06	0.000137	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALB—epilepsy syndrome	2.19e-06	0.000136	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.16e-06	0.000134	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.01e-06	0.000124	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.92e-06	0.000119	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.76e-06	0.000109	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.73e-06	0.000107	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.48e-06	9.18e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.35e-06	8.37e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.18e-06	7.32e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AKT1—epilepsy syndrome	9.65e-07	5.97e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5.94e-07	3.68e-05	CbGpPWpGaD
